Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland

NCT01630226 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

BRCA1 Mutation
Breast Cancer Invasive Nos

Interventions

DRUG: Neoadjuvant Cisplatin Chemotherapy

Sponsor

Pomeranian Medical University Szczecin

Collaborators

[object Object]
[object Object]